Ducommun - 10-Q quarterly report FY2014 Q3

Ducommun - 10-Q quarterly report FY2014 Q3

What is the market capitalization of a company?

DISCLAIMER

Contact

Links

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________________________________________________

FORM 10-Q

_________________________________________________________



x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 27, 2014



¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 1-8174

_________________________________________________________

DUCOMMUN INCORPORATED

(Exact name of registrant as specified in its charter)

_________________________________________________________



Delaware		95-0693330
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

23301 Wilmington Avenue, Carson, California		90745-6209
(Address of principal executive offices)		(Zip code)

Registrant’s telephone number, including area code: (310) 513-7200

(Former name, former address and former fiscal year, if changed since last report)

_________________________________________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.



Large accelerated filer	¨	Accelerated filer	x

Non-accelerated filer	¨	Smaller reporting company	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

As of October 13, 2014, the registrant had 10,945,806 shares of common stock outstanding.

Table of Contents

DUCOMMUN INCORPORATED AND SUBSIDIARIES



			Page
PART I. FINANCIAL INFORMATION

	Item 1.	Financial Statements (unaudited)	3

		Condensed Consolidated Balance Sheets as of September 27, 2014 and December 31, 2013	3

		Condensed Consolidated Statements of Income for the Three and Nine Months Ended September 27, 2014 and September 28, 2013	4

		Condensed Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended September 27, 2014 and September 28, 2013	5

		Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 27, 2014 and September 28, 2013	6

		Notes to Condensed Consolidated Financial Statements	7

	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	15

	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	24

	Item 4.	Controls and Procedures	24

PART II. OTHER INFORMATION

	Item 1.	Legal Proceedings	24

	Item 1A.	Risk Factors	25

	Item 4.	Mine Safety Disclosures	25

	Item 6.	Exhibits	26

Signatures			28

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

Ducommun Incorporated and Subsidiaries

Condensed Consolidated Balance Sheets

(Unaudited)

(In thousands, except share and per share data)



	September 27,			December 31,
	2014			2013
Assets
Current Assets
Cash and cash equivalents	$	40,852		$	48,814
Accounts receivable, net of allowance for doubtful accounts of $275 and $489 at September 27, 2014 and December 31, 2013, respectively	104,396			91,909
Inventories	145,468			140,507
Production cost of contracts	10,375			11,599
Deferred income taxes	13,664			10,850
Other current assets	20,444			27,085
Total Current Assets	335,199			330,764
Property and Equipment, Net	93,181			96,090
Goodwill	161,940			161,940
Intangibles, Net	157,694			165,465
Other Assets	7,657			9,940
Total Assets	$	755,671		$	764,199
Liabilities and Shareholders’ Equity
Current Liabilities
Current portion of long-term debt	$	26		$	25
Accounts payable	55,083			58,111
Accrued liabilities	42,916			45,453
Total Current Liabilities	98,025			103,589
Long-Term Debt, Less Current Portion	310,157			332,677
Deferred Income Taxes	73,078			68,489
Other Long-Term Liabilities	16,858			19,750
Total Liabilities	498,118			524,505
Commitments and Contingencies (Notes 8, 10)
Subsequent Event (Note 10)
Shareholders’ Equity
Common stock - $0.01 par value; 35,000,000 shares authorized; 10,945,806 and 10,960,054 issued at September 27, 2014 and December 31, 2013, respectively	109			110
Treasury stock, at cost; zero and 143,300 shares at September 27, 2014 and December 31, 2013, respectively	—			(1,924		)
Additional paid-in capital	72,563			70,542
Retained earnings	188,551			174,828
Accumulated other comprehensive loss	(3,670		)	(3,862		)
Total Shareholders’ Equity	257,553			239,694
Total Liabilities and Shareholders’ Equity	$	755,671		$	764,199

See accompanying notes to condensed consolidated financial statements.

Table of Contents

Ducommun Incorporated and Subsidiaries

Condensed Consolidated Income Statements

(Unaudited)

(In thousands, except per share amounts)



	Three Months Ended						Nine Months Ended
	September 27, 2014			September 28, 2013			September 27, 2014			September 28, 2013
Net Revenues	$	188,164		$	181,288		$	554,433		$	548,675
Cost of Sales	154,770			148,984			448,526			446,202
Gross Profit	33,394			32,304			105,907			102,473
Selling, General and Administrative Expenses	23,050			20,351			65,005			65,175
Operating Income	10,344			11,953			40,902			37,298
Interest Expense	(6,975		)	(7,403		)	(21,094		)	(22,668		)
Other Income	1,600			—			1,600			—
Income Before Taxes	4,969			4,550			21,408			14,630
Income Tax Expense (Benefit)	2,347			(86		)	7,685			783
Net Income	$	2,622		$	4,636		$	13,723		$	13,847
Earnings Per Share
Basic earnings per share	$	0.24		$	0.43		$	1.26		$	1.30
Diluted earnings per share	$	0.24		$	0.42		$	1.23		$	1.28
Weighted-Average Number of Common Shares Outstanding
Basic	10,921			10,722			10,902			10,657
Diluted	11,150			10,917			11,202			10,785

See accompanying notes to condensed consolidated financial statements.

Table of Contents

Ducommun Incorporated and Subsidiaries

Condensed Consolidated Statements of Comprehensive Income

(Unaudited)

(In thousands)



	Three Months Ended						Nine Months Ended
	September 27, 2014			September 28, 2013			September 27, 2014			September 28, 2013
Net Income	$	2,622		$	4,636		$	13,723		$	13,847
Other Comprehensive Loss
Amortization of actuarial loss and prior service costs, net of tax benefit of approximately $40 and $102 for the three months ended September 27, 2014 and September 28, 2013, respectively, and approximately $124 and $306 for the nine months ended September 27, 2014 and September 28, 2013, respectively	(66		)	(172		)	(192		)	(516		)
Other Comprehensive Loss	(66		)	(172		)	(192		)	(516		)
Comprehensive Income	$	2,556		$	4,464		$	13,531		$	13,331

See accompanying notes to condensed consolidated financial statements.

Table of Contents

Ducommun Incorporated and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(In thousands)



	Nine Months Ended
	September 27, 2014			September 28, 2013
Cash Flows from Operating Activities
Net Income	$	13,723		$	13,847
Adjustments to Reconcile Net Income to
Net Cash Provided by Operating Activities:
Depreciation and amortization	21,829			21,375
Stock-based compensation expense	2,520			1,711
Deferred income taxes	1,775			45
Recovery of doubtful accounts	(214		)	(141		)
Other	649			1,434
Changes in Assets and Liabilities:
Accounts receivable	(12,273		)	4,804
Inventories	(4,961		)	(206		)
Production cost of contracts	(1,408		)	(3,396		)
Other assets	7,121			(9,033		)
Accounts payable	(2,447		)	(2,910		)
Accrued and other liabilities	(5,400		)	(12,819		)
Net Cash Provided by Operating Activities	20,914			14,711
Cash Flows from Investing Activities
Purchases of property and equipment	(9,329		)	(7,321		)
Proceeds from sale of assets	83			123
Insurance recoveries related to property and equipment	1,600			—
Net Cash Used in Investing Activities	(7,646		)	(7,198		)
Cash Flows from Financing Activities
Repayment of term loan and other debt	(22,519		)	(22,518		)
Debt issue cost paid	—			(181		)
Net proceeds from issuance of common stock under stock plans	1,289			1,246
Net Cash Used in Financing Activities	(21,230		)	(21,453		)
Net Decrease in Cash and Cash Equivalents	(7,962		)	(13,940		)
Cash and Cash Equivalents at Beginning of Period	48,814			46,537
Cash and Cash Equivalents at End of Period	$	40,852		$	32,597
Supplemental Disclosures of Cash Flow Information
Interest paid	$	24,090		$	25,640
Taxes paid	$	3,410		$	6,542
Non-cash activities:
Purchases of property and equipment not paid	$	418		$	—

See accompanying notes to condensed consolidated financial statements.

Table of Contents

Ducommun Incorporated and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 1. Summary of Significant Accounting Policies

Basis of Presentation

The unaudited condensed consolidated financial statements include the accounts of Ducommun Incorporated and its subsidiaries (“Ducommun,” the “Company,” “we,” “us” or “our”), after eliminating intercompany balances and transactions. The December 31, 2013 condensed consolidated balance sheet data was derived from audited financial statements, but does not contain all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”).

Our significant accounting policies were described in Part IV, Item 15(a)(1), “Note 1. Summary of Significant Accounting Policies” in our Annual Report on Form 10-K for the year ended December 31, 2013. We followed the same accounting policies for interim reporting. The financial information included in this Quarterly Report on Form 10-Q should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2013.

In the opinion of management, all adjustments, consisting of recurring accruals, have been made that are necessary to fairly state our condensed consolidated financial position, statements of income, comprehensive income and cash flows in accordance with GAAP for the periods covered by this Quarterly Report on Form 10-Q. The results of operations for the three and nine months ended September 27, 2014 are not necessarily indicative of the results to be expected for the full year ending December 31, 2014.

Our fiscal quarters end on the Saturday closest to the end of March, June and September for the first three fiscal quarters of each year, and ends on December 31 for our fourth fiscal quarter.

Certain reclassifications have been made to prior period amounts to conform to the current year’s presentation.

Use of Estimates

Certain amounts and disclosures included in the unaudited condensed consolidated financial statements required management to make estimates and judgments that affect the amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

Description of Business

We are a leading global provider of engineering and manufacturing services for high-performance products and high-cost-of failure applications used primarily in the aerospace, defense, industrial, natural resources, medical and other industries. Our subsidiaries are organized into two strategic businesses: Ducommun AeroStructures (“DAS”) and Ducommun LaBarge Technologies (“DLT”), each of which is a reportable operating segment. DAS designs, engineers and manufactures large, complex contoured aerospace structural components and assemblies and supplies composite and metal bonded structures and assemblies. DAS products are used on commercial aircraft, military fixed-wing aircraft and military and commercial rotary-wing aircraft. DLT designs, engineers and manufactures high-reliability products used in worldwide technology-driven markets including aerospace and defense, natural resources, industrial and medical and other end-use markets. DLT’s product offerings range from prototype development to complex assemblies. All reportable operating segments follow the same accounting principles.

Earnings Per Share

Basic earnings per share are computed by dividing income available to common shareholders by the weighted-average number of common shares outstanding in each period. Diluted earnings per share are computed by dividing income available to common shareholders plus income associated with dilutive securities by the weighted-average number of common shares outstanding, plus any potential dilutive shares that could be issued if exercised or converted into common stock in each period.

The net earnings, weighted-average number of common shares outstanding used to compute earnings per share were as follows:

Table of Contents



	(In thousands, except per share data) Three Months Ended				(In thousands, except per share data) Nine Months Ended
	September 27, 2014		September 28, 2013		September 27, 2014		September 28, 2013
Net earnings	$	2,622	$	4,636	$	13,723	$	13,847
Weighted-average number of common shares outstanding
Basic weighted-average common shares outstanding	10,921		10,722		10,902		10,657
Dilutive potential common shares	229		195		300		128
Diluted weighted-average common shares outstanding	11,150		10,917		11,202		10,785
Earnings per share
Basic	$	0.24	$	0.43	$	1.26	$	1.30
Diluted	$	0.24	$	0.42	$	1.23	$	1.28

Potentially dilutive stock options and stock units to purchase common stock, as shown below, were excluded from the computation of diluted earnings per share because their inclusion would have been anti-dilutive. However, these shares may be potentially dilutive common shares in the future.

(In thousands)

Three Months Ended

(In thousands)
Nine Months Ended

September 27,
2014

September 28,
2013

September 27,
2014

September 28,
2013

Stock options and stock units

229

219

187

612

Cash and Cash Equivalents

Our cash accounts are not reduced for checks written until the checks are presented for payment and paid by our bank. Cash equivalents consist of highly liquid instruments purchased with original maturities of three months or less. These assets are valued at cost, which approximates fair value, which we classify as Level 1. See Fair Value below.

Provision for Estimated Losses on Contracts

Provisions for estimated losses on contracts are recorded during the period in which it is determined that total anticipated contract costs will exceed total anticipated contract revenues. The provisions for estimated losses on contracts require management to make certain estimates and assumptions, including those with respect to the future revenue under a contract and the future cost to complete the contract. Management's estimate of the future cost to complete a contract may include assumptions as to improvements in manufacturing efficiency, reductions in operating and material costs, and our ability to resolve claims and assertions with our customers. If any of these or other assumptions and estimates do not materialize in the future, we may be required to record additional provisions for estimated losses on contracts.

Inventory Valuation

Inventories are stated at the lower of cost or market, cost being determined on a first-in, first-out basis. Market value for raw materials is based on replacement costs, and is based on net realizable value for other inventory classifications. Inventoried costs include raw materials, outside processing, direct labor and allocated overhead, adjusted for any abnormal amounts of idle facility expense, freight, handling costs, and wasted materials (spoilage) incurred. Costs under long-term contracts are accumulated into, and removed from, inventory on the same basis as other contracts. We assess the inventory carrying value and reduce it, if necessary, to its net realizable value based on customer orders on hand, and internal demand forecasts using management’s best estimates given information currently available. We maintain an allowance for potentially excess and obsolete inventories and inventories that are carried at costs that are higher than their estimated net realizable values.

Out of Period Adjustments

During the third quarter of 2013, we determined that approximately $1.1 million of inventory had not been valued correctly at our DLT operating segment for periods originating in 2010 through the second quarter of 2013. The errors were attributed to the following quarters; $0.3 million in Q2 2010, $0.5 million in Q2 2011, $0.1 million in Q4 2012, $0.1 million in Q1 2013 and $0.1 million in Q2 2013. We assessed the materiality of these errors and concluded they were immaterial to currently reported annual amounts and previously reported annual and interim amounts. We corrected the errors in the third quarter of 2013 and recorded a $1.1 million charge for inventory reserves for the DLT operating segment and did not restate our condensed consolidated financial statements for the prior annual or interim periods.

Table of Contents

Production Cost of Contracts

Production cost of contracts includes non-recurring production costs, such as design and engineering costs, and tooling and other special-purpose machinery necessary to build parts as specified in a contract. Production costs of contracts are recorded to cost of goods sold using the units of delivery method. We review long-lived assets within production costs of contracts for impairment on an annual basis (in the fourth quarter for us) or when events or changes in circumstances indicate that the carrying value of our long-lived assets may not be recoverable. An impairment charge is recognized when the carrying value of an asset exceeds the projected undiscounted future cash flows expected from its use and disposal.

Fair Value

Assets and liabilities that are measured, recorded or disclosed at fair value on a recurring basis are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. Level 1, the highest level, refers to the values determined based on quoted prices in active markets for identical assets. Level 2 refers to fair values estimated using significant observable inputs. Level 3, the lowest level, includes fair values estimated using significant unobservable inputs.

Accumulated Other Comprehensive Loss

Accumulated other comprehensive loss, as reflected in the condensed consolidated balance sheets under the equity section, was comprised of cumulative pension and retirement liability adjustments, net of tax.

Recent Accounting Pronouncements

New Accounting Standards Adopted in 2014

In July 2013, the FASB issued Accounting Standards Update 2013-11, “Income Taxes (Topic 740)” (“ASU 2013-11”), which required the netting of unrecognized tax benefits against a deferred tax asset for a loss or other carryforward that would apply in settlement of the uncertain tax positions. This guidance was effective for fiscal years beginning after December 15, 2013, which is our fiscal year 2014, with early adoption permitted. The adoption of this standard at the beginning of our fiscal year 2014 reduced deferred tax assets by approximately $0.6 million as of September 27, 2014.

In February 2013, the FASB issued ASU 2013-04, “Liabilities (Topic 405)” (“ASU 2013-04”), which provided guidance for the recognition, measurement and disclosure of obligations resulting from joint and several liability arrangements for which the total amount of the obligation is fixed at the reporting date, except for obligations addressed within existing guidance in GAAP. The new guidance was effective for us beginning January 1, 2014. Early adoption was permitted. The adoption of this standard at the beginning of our fiscal year 2014 did not have a material impact on our condensed consolidated financial statements.

Recently Issued Accounting Standards

In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-15”), which defines management’s responsibility to evaluate whether there is substantial doubt about a company’s ability to continue as a going concern. ASU 2014-15 also provide principles and definitions that are intended to reduce diversity in the timing and content of disclosures in the financial statement footnotes. The new guidance is effective for annual periods ending after December 15, 2016, which will be our year ending December 31, 2016, and interim periods beginning after December 15, 2016, which will be our interim period beginning January 1, 2017. Early adoption is permitted. We are evaluating the impact of this standard but currently do not anticipate it will have a significant impact on our condensed consolidated financial statements.

In June 2014, the FASB issued ASU 2014-12, “Compensation - Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide that a Performance Target Could be Achieved after the Requisite Service Period” (“ASU 2014-12”), which requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. Thus, the performance target should not be reflected in estimating the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. The new guidance is effective for us beginning January 1, 2016. Early adoption is permitted. We currently do not anticipate the adoption of this standard will have a material impact on our condensed consolidated financial statements.

In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)” (“ASU 2014-09”), which

Table of Contents

outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. This new revenue recognition model provides a five-step analysis in determining when and how revenue is recognized. It requires entities to exercise judgment when considering the terms of the contract(s) which include (i) identifying the contract(s) with the customer, (ii) identifying the separate performance obligations in the contract, (iii) determining the transaction price, (iv) allocating the transaction price to the separate performance obligations, and (v) recognizing revenue when each performance obligation is satisfied. Thus, it depicts the transfer of promised goods or services to customers in an amount that reflects the consideration an entity expects to receive in exchange for those goods or services. Companies have the option of applying the provisions of ASU 2014-09 either retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying this guidance recognized at the date of initial application. Early adoption is not permitted. The new guidance is effective for us beginning January 1, 2017. We are currently evaluating the method and impact that adopting this new accounting standard will have on our condensed consolidated financial statements.

Note 2. Inventories

Inventories consisted of the following:



	(In thousands)
	September 27,		December 31,
	2014		2013
Raw materials and supplies	$	79,150	$	75,985
Work in process	68,746		62,115
Finished goods	8,766		11,580
	156,662		149,680
Less progress payments	11,194		9,173
Total	$	145,468	$	140,507

Note 3. Goodwill

The carrying amounts of goodwill, by operating segment, were as follows:



	(In thousands)
	Ducommun AeroStructures		Ducommun LaBarge Technologies			Consolidated Ducommun
Gross goodwill	$	57,243	$	184,970		$	242,213
Accumulated goodwill impairment	—		(80,273		)	(80,273		)
Balance at December 31, 2013	$	57,243	$	104,697		$	161,940
Balance at September 27, 2014	$	57,243	$	104,697		$	161,940

Note 4. Accrued Liabilities

The components of accrued liabilities were as follows:



	(In thousands)
	September 27,		December 31,
	2014		2013
Accrued compensation	$	22,768	$	19,929
Accrued income and sales tax	1,446		1,451
Customer deposits	1,342		3,236
Interest payable	4,227		8,965
Provision for forward loss reserves	5,123		4,825
Other	8,010		7,047
Total	$	42,916	$	45,453

Table of Contents

Note 5. Long-Term Debt

Long-term debt and the current period interest rates were as follows:



	(In thousands)
	September 27,			December 31,
	2014			2013
Senior unsecured notes (fixed 9.75%)	$	200,000		$	200,000
Senior secured term loan (floating 4.75%)	110,125			132,625
Other debt (fixed 5.41%)	58			77
Total Debt	310,183			332,702
Less current portion	26			25
Total long-term debt	$	310,157		$	332,677
Weighted-average interest rate	7.97		%	7.76		%

We made a voluntary principal prepayment on our senior secured term loan of approximately $7.5 million each quarter for an aggregate total of approximately $22.5 million in both the nine months ended September 27, 2014 and September 28, 2013.

As of September 27, 2014, we had approximately $58.5 million of unused borrowing capacity under the revolving credit facility, after deducting approximately $1.5 million for standby letters of credit.

As of September 27, 2014, we were in compliance with all covenants required by our amended credit agreement. Also as of September 27, 2014, there were no amounts outstanding that would have triggered the leverage covenant under the Amended Credit Agreement. Under the terms of the credit agreement, if, during a given fiscal quarter, (i) the sum of (a) any amounts outstanding under the revolving credit facility plus (b) the amount drawn under any letters of credit exceeds $1.0 million or (ii) the aggregate amount of outstanding letters of credit exceeds $5.0 million, the revolving credit facility will be subject to a maximum total leverage ratio.

The carrying amount of our long-term debt approximated fair value, except for the senior unsecured notes for which the fair value was approximately $215.0 million. Fair value was estimated using Level 2 inputs, based on the terms of the related debt, recent transactions and estimates using interest rates currently available to us for debt with similar terms and remaining maturities.

Note 6. Shareholders’ Equity

We are authorized to issue five million shares of preferred stock. At September 27, 2014 and December 31, 2013, no preferred shares were issued or outstanding.

Note 7. Employee Benefit Plans

The components of net periodic pension expense were as follows:



	(In thousands)						(In thousands)
	Three Months Ended						Nine Months Ended
	September 27, 2014			September 28, 2013			September 27, 2014			September 28, 2013
Service cost	$	174		$	211		$	520		$	633
Interest cost	320			290			958			870
Expected return on plan assets	(351		)	(306		)	(1,052		)	(918		)
Amortization of actuarial losses	106			274			316			822
Net periodic pension cost	$	249		$	469		$	742		$	1,407

The components of the reclassifications of net actuarial losses from accumulated other comprehensive loss to net income for the three and nine months ended September 27, 2014 were as follows:

Table of Contents



	(In thousands)
	Three Months Ended			Nine Months Ended
	September 27, 2014			September 27, 2014
Amortization of actuarial loss - total before tax ⁽¹⁾	$	(106	)	$	(316	)
Tax benefit	40			124
Net of tax	$	(66	)	$	(192	)


(1)	The amortization expense is included in the computation of periodic pension cost and is a decrease to net income upon reclassification from accumulated other comprehensive loss.

Note 8. Indemnifications

We have made guarantees and indemnities under which we may be required to make payments to a guaranteed or indemnified party, in relation to certain transactions, including revenue transactions in the ordinary course of business. In connection with certain facility leases, we have indemnified our lessors for certain claims arising from the facility or the lease. We indemnify our directors and officers to the maximum extent permitted under the laws of the State of Delaware.

However, we have a directors and officers insurance policy that may reduce our exposure in certain circumstances and may enable us to recover a portion of future amounts that may be payable, if any. The duration of the guarantees and indemnities varies and, in many cases is indefinite but subject to statute of limitations. The majority of guarantees and indemnities do not provide any limitations of the maximum potential future payments we could be obligated to make. Historically, payments related to these guarantees and indemnities have been immaterial. We estimate the fair value of our indemnification obligations as insignificant based on this history and insurance coverage and have, therefore, not recorded any liability for these guarantees and indemnities in the accompanying condensed consolidated balance sheets.

Note 9. Income Taxes

We recorded income tax expense of approximately $2.3 million (effective tax rate of 47.2%) for the three months ended September 27, 2014 compared to an income tax benefit of approximately $0.1 million (effective tax benefit rate of 1.9%) for the three months ended September 28, 2013. The effective tax rate for for the three months ended September 27, 2014 did not include a benefit from the federal research and development (“R&D”) tax credit as it expired on December 31, 2013. The three months ended September 28, 2013 included a federal R&D tax credit benefit of approximately $0.7 million. In addition, the effective tax rate for the three months ended September 27, 2014 included a total of approximately $0.9 million additional tax expense as a result of lowering our Qualified Domestic Production Activities Deduction due to lower taxable income as a result of tax returns filed or to be filed.

We recorded income tax expense of approximately $7.7 million (effective tax rate of 35.9%) for the nine months ended September 27, 2014 compared to approximately $0.8 million (effective tax rate of 5.4%) for the nine months ended September 28, 2013. The effective tax rate for for the nine months ended September 27, 2014 did not include a benefit from the federal R&D tax credit as it expired on December 31, 2013. The nine months ended September 28, 2013 included a federal R&D tax credit benefit of approximately $3.7 million. This amount included approximately $2.0 million of 2012 federal research and development tax credits benefit recognized in the nine months ended September 28, 2013 as a result of the American Taxpayer Relief Act of 2012 (the “Act”) passed in January 2013. The Act included an extension of the federal R&D tax credit for amounts paid or incurred during 2012 and 2013.

Our unrecognized tax benefits were approximately $2.6 million both as of September 27, 2014 and December 31, 2013, respectively. Most of these amounts, if recognized, would affect the annual income tax rate. It is reasonably possible that the unrecognized tax benefits could be reduced by approximately $0.4 million in the next twelve months.

Table of Contents

Note 10. Contingencies

Ducommun is a defendant in a lawsuit entitled United States of America ex rel Taylor Smith, Jeannine Prewitt and James Ailes v. The Boeing Company and Ducommun Inc., filed in the United States District Court for the District of Kansas (the “District Court”). The lawsuit is a qui tam action brought by three former The Boeing Company (“Boeing”) employees (“Relators”) against Boeing and Ducommun on behalf of the United States of America for violations of the United States False Claims Act. The lawsuit alleges that Ducommun sold unapproved parts to Boeing which were installed by Boeing in aircraft ultimately sold to the United States Government and that Boeing and Ducommun submitted or caused to be submitted false claims for payment relating to 21 aircraft sold by Boeing to the United States Government. The lawsuit seeks damages in an amount equal to three times the amount of damages the United States Government sustained because of the defendants’ actions, plus a civil penalty of $10 thousand for each false claim made on or before September 28, 1999, and $11 thousand for each false claim made on or after September 28, 1999, together with attorneys’ fees and costs. The Relators claim that the United States Government sustained damages of $1.6 billion (the contract purchase price of 21 aircraft) or, alternatively, $851 million (the alleged diminished value and increased maintenance cost of the 21 aircraft). After investigating the allegations, the United States Government has declined to intervene in the lawsuit. Subsequent to the Company’s quarter ended September 27, 2014, on October 8, 2014, the District Court granted summary judgment in favor of Boeing and Ducommun and dismissed the lawsuit. The District Court’s decision remains subject to appeal.

DAS has been directed by California environmental agencies to investigate and take corrective action for groundwater contamination at its facilities located in El Mirage and Monrovia, California. Based on currently available information, Ducommun has established a reserve for its estimated liability for such investigation and corrective action of approximately $1.5 million at September 27, 2014, which is reflected in other long-term liabilities on the condensed consolidated balance sheet.

DAS also faces liability as a potentially responsible party for hazardous waste disposed at landfills located in Casmalia and West Covina, California. DAS and other companies and government entities have entered into consent decrees with respect to these landfills with the United States Environmental Protection Agency and/or California environmental agencies under which certain investigation, remediation and maintenance activities are being performed. Based on currently available information, Ducommun preliminarily estimates that the range of its future liabilities in connection with the landfill located in West Covina, California is between approximately $0.4 million and $3.1 million. Ducommun has established a reserve for its estimated liability, in connection with the West Covina landfill of approximately $0.4 million at September 27, 2014, which is reflected in other long-term liabilities on its condensed consolidated balance sheet. Ducommun’s ultimate liability in connection with these matters will depend upon a number of factors, including changes in existing laws and regulations, the design and cost of construction, operation and maintenance activities, and the allocation of liability among potentially responsible parties.

In the normal course of business, Ducommun and its subsidiaries are defendants in certain other litigation, claims and inquiries, including matters relating to environmental laws. In addition, Ducommun makes various commitments and incurs contingent liabilities. While it is not feasible to predict the outcome of these matters, Ducommun does not presently expect that any sum it may be required to pay in connection with these matters would have a material adverse effect on its condensed consolidated financial position, results of operations or cash flows.

Note 11. Business Segment Information

We supply products and services primarily to the aerospace and defense industries. Our subsidiaries are organized into two strategic businesses, DAS and DLT, each of which is a reportable operating segment.

Financial information by reportable operating segment was as follows:

Table of Contents



	(In thousands) Three Months Ended						(In thousands) Nine Months Ended
	September 27,			September 28,			September 27,			September 28,
	2014			2013			2014			2013
Net Revenues
DAS	$	81,357		$	77,740		$	241,627		$	234,437
DLT	106,807			103,548			312,806			314,238
Total Net Revenues	$	188,164		$	181,288		$	554,433		$	548,675
Segment Operating Income
DAS	$	7,190		$	7,633		$	27,269		$	23,766
DLT	8,288			7,596			26,089			26,772
	15,478			15,229			53,358			50,538
Corporate General and Administrative Expenses ⁽¹⁾	(5,134		)	(3,276		)	(12,456		)	(13,240		)
Operating Income	$	10,344		$	11,953		$	40,902		$	37,298
Depreciation and Amortization Expenses
DAS	$	2,272		$	2,621		$	8,242		$	7,386
DLT	4,391			4,540			13,442			13,863
Corporate Administration	41			41			145			126
Total Depreciation and Amortization Expenses	$	6,704		$	7,202		$	21,829		$	21,375
Capital Expenditures
DAS	$	1,266		$	1,159		$	3,986		$	4,208
DLT	1,761			866			4,736			3,046
Corporate Administration	1			43			25			67
Total Capital Expenditures	$	3,028		$	2,068		$	8,747		$	7,321


(1)	Includes costs not allocated to either the DLT or DAS operating segments.

Segment assets include assets directly identifiable with each segment. Corporate assets include assets not specifically identified with a business segment, including cash. Our segment assets are as follows:



	(In thousands)
	September 27, 2014		December 31, 2013
Total Assets
DAS	$	244,207	$	241,502
DLT	441,443		444,224
Corporate Administration	70,021		78,473
Total Assets	$	755,671	$	764,199
Goodwill and Intangibles
DAS	$	63,926	$	65,213
DLT	255,708		262,192
Total Goodwill and Intangibles	$	319,634	$	327,405

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

Ducommun Incorporated (“Ducommun,” the “Company,” “we,” “us” or “our”) is a leading global provider of engineering and manufacturing services for high-performance products and high-cost-of failure applications used primarily in the aerospace, defense, industrial, natural resources, medical and other industries. Ducommun differentiates itself as a full-service solution-based provider, offering a wide range of value-added products and services in our primary businesses of electronics, structures and integrated solutions. We operate through two primary business units: Ducommun LaBarge Technologies (“DLT”) and Ducommun AeroStructures (“DAS”).

Third quarter 2014 highlights were as follows:


•	Third quarter revenue was $188.2 million


•	We reported net income of $2.6 million, or $0.24 per diluted share


•	EBITDA for the quarter was $18.6 million


•	We made a voluntary principal prepayment of $7.5 million on our term loan during the quarter

Earnings before interest, taxes, depreciation and amortization (“EBITDA”) was approximately $18.6 million and $19.2 million for the three months ended September 27, 2014 and September 28, 2013, respectively. See “Non-GAAP Financial Measures” below for certain information regarding EBITDA, including reconciliation of EBITDA to net income.

Non-GAAP Financial Measures

When viewed with our financial results prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and accompanying reconciliations, we believe EBITDA provides additional useful information to clarify and enhance the understanding of the factors and trends affecting our past performance and future prospects. We define these measures, explain how they are calculated and provide reconciliations of these measures to the most comparable GAAP measure in the tables below. EBITDA and the related financial ratios, as presented in this Form 10-Q, are supplemental measures of our performance that are not required by, or presented in accordance with, GAAP. They are not a measurement of our financial performance under GAAP and should not be considered as alternatives to net income or any other performance measures derived in accordance with GAAP, or as an alternative to net cash provided by operating activities as measures of our liquidity. The presentation of these measures should not be interpreted to mean that our future results will be unaffected by unusual or nonrecurring items.

We use EBITDA as a non-GAAP operating performance measure internally as complementary financial measures to evaluate the performance and trends of our businesses. We present EBITDA and the related financial ratios, as applicable, because we believe that measures such as these provide useful information with respect to our ability to meet our future debt service, capital expenditures, working capital requirements and overall operating performance.

EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as substitutes for analysis of our results as reported under GAAP. Some of these limitations are:


•	They do not reflect our cash expenditures, future requirements for capital expenditures or contractual commitments;


•	They do not reflect changes in, or cash requirements for, our working capital needs;


•	They do not reflect the significant interest expense or the cash requirements necessary to service interest or principal payments on our debt;


•	Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and EBITDA does not reflect any cash requirements for such replacements;


•	They are not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows;


•	They do not reflect the impact on earnings of charges resulting from matters unrelated to our ongoing operations; and


•	Other companies in our industry may calculate EBITDA differently from us, limiting their usefulness as comparative measures.

Table of Contents

Because of these limitations, EBITDA and the related financial ratios should not be considered as measures of discretionary cash available to us to invest in the growth of our business or as a measure of cash that will be available to us to meet our obligations. You should compensate for these limitations by relying primarily on our GAAP results and using EBITDA as only supplemental information. See our condensed consolidated financial statements contained in this Form 10-Q report.

However, in spite of the above limitations, we believe that EBITDA is useful to an investor in evaluating our results of operations because these measures:


•	Are widely used by investors to measure a company’s operating performance without regard to items excluded from the calculation of such terms, which can vary substantially from company to company depending upon accounting methods and book value of assets, capital structure and the method by which assets were acquired, among other factors;


•	Help investors to evaluate and compare the results of our operations from period to period by removing the effect of our capital structure from our operating performance; and


•	Are used by our management team for various other purposes in presentations to our Board of Directors as a basis for strategic planning and forecasting.

The following financial items have been added back to our net income when calculating EBITDA:


•	Amortization expense may be useful to investors because it represents the estimated attrition of our acquired customer base and the diminishing value of product rights;


•	Depreciation may be useful to investors because it generally represents the wear and tear on our property and equipment used in our operations;


•	Interest expense may be useful to investors for determining current cash flow; and


•	Income tax expense may be useful to investors because it represents the taxes which may be payable for the period and the change in deferred taxes during the period, and may reduce cash flow available for use in our business.

Reconciliations of net income to EBITDA and the presentation of EBITDA as a percentage of net revenues were as follows:



	(In thousands) Three Months Ended						(In thousands) Nine Months Ended
	September 27,			September 28,			September 27,			September 28,
	2014			2013			2014			2013
Net income	$	2,622		$	4,636		$	13,723		$	13,847
Depreciation and amortization	6,704			7,202			21,829			21,375
Interest expense	6,975			7,403			21,094			22,668
Income tax expense	2,347			(86		)	7,685			783
EBITDA	$	18,648		$	19,155		$	64,331		$	58,673
% of net revenues	9.9		%	10.6		%	11.6		%	10.7		%

EBITDA decreased in the three months ended September 27, 2014 compared to the three months ended September 28, 2013, primarily due to decreases in net income, depreciation and amortization expense, and interest expense, partially offset by higher income tax expense.

EBITDA increased in the nine months ended September 27, 2014 compared to the nine months ended September 28, 2013, primarily due to higher income tax expense.

Table of Contents

Results of Operations

Third Quarter of 2014 Compared to Third Quarter of 2013

The following table sets forth net revenues, selected financial data, the effective tax rate and diluted earnings per share:



	(in thousands, except per share data) Three Months Ended										(in thousands, except per share data) Nine Months Ended
	September 27, 2014			% of Net Revenues		September 28, 2013			% of Net Revenues		September 27, 2014			% of Net Revenues		September 28, 2013			% of Net Revenues
Net Revenues	$	188,164		100.0	%	$	181,288		100.0	%	$	554,433		100.0	%	$	548,675		100.0	%
Cost of Sales	154,770			82.3	%	148,984			82.2	%	448,526			80.9	%	446,202			81.3	%
Gross Profit	33,394			17.7	%	32,304			17.8	%	105,907			19.1	%	102,473			18.7	%
Selling, General and Administrative Expenses	23,050			12.2	%	20,351			11.2	%	65,005			11.7	%	65,175			11.9	%
Operating Income	10,344			5.5	%	11,953			6.6	%	40,902			7.4	%	37,298			6.8	%
Interest Expense	(6,975		)	(3.7	)%	(7,403		)	(4.1	)%	(21,094		)	(3.8	)%	(22,668		)	(4.1	)%
Other Income	1,600			0.9	%	—			—	%	1,600			0.3	%	—			—	%
Income Before Taxes	4,969			2.6	%	4,550			2.5	%	21,408			3.9	%	14,630			2.7	%
Income Tax Expense (Benefit)	2,347			nm		(86		)	nm		7,685			nm		783			nm
Net Income	$	2,622		1.4	%	$	4,636		2.6	%	$	13,723		2.5	%	$	13,847		2.5	%

Effective Tax Expense (Benefit) Rate	47.2		%	nm		(1.9		)%	nm		35.9		%	nm		5.4		%	nm
Diluted Earnings Per Share	$	0.24		nm		$	0.42		nm		$	1.23		nm		$	1.28		nm

nm = not meaningful

Net Revenues by End-Use Market and Operating Segment

Net revenues by end-use market and operating segment during the three and nine months of 2014 and 2013, respectively, were as follows:

Table of Contents



	Three Months Ended									Nine Months Ended
				(In thousands)				% of Net Revenues					(In thousands)				% of Net Revenues
	Change			September 27, 2014		September 28, 2013		September 27, 2014	September 28, 2013	Change			September 27, 2014		September 28, 2013		September 27, 2014	September 28, 2013
Consolidated Ducommun
Military and space
Defense technologies	$	(402	)	$	63,552	$	63,954	34%	34%	$	(10,992	)	$	183,393	$	194,385	32%	36%
Defense structures	(2,877		)	32,547		35,424		17%	20%	(2,674		)	97,122		99,796		18%	18%
Commercial aerospace	10,644			62,455		51,811		33%	29%	16,110			177,405		161,295		32%	29%
Natural resources	1,023			10,358		9,335		6%	5%	3,536			31,924		28,388		6%	5%
Industrial	(2,442		)	9,609		12,051		5%	7%	(2,165		)	31,428		33,593		6%	6%
Medical and other	930			9,643		8,713		5%	5%	1,943			33,161		31,218		6%	6%
Total	$	6,876		$	188,164	$	181,288	100%	100%	$	5,758		$	554,433	$	548,675	100%	100%

DAS
Military and space (defense structures)	$	(2,877	)	$	32,547	$	35,424	40%	46%	$	(2,674	)	$	97,122	$	99,796	40%	43%
Commercial aerospace	6,494			48,810		42,316		60%	54%	9,864			144,505		134,641		60%	57%
Total	$	3,617		$	81,357	$	77,740	100%	100%	$	7,190		$	241,627	$	234,437	100%	100%

DLT
Military and space (defense technologies)	$	(402	)	$	63,552	$	63,954	60%	62%	$	(10,992	)	$	183,393	$	194,385	58%	62%
Commercial aerospace	4,150			13,645		9,495		13%	9%	6,246			32,900		26,654		11%	8%
Natural resources	1,023			10,358		9,335		9%	9%	3,536			31,924		28,388		10%	9%
Industrial	(2,442		)	9,609		12,051		9%	12%	(2,165		)	31,428		33,593		10%	11%
Medical and other	930			9,643		8,713		9%	8%	1,943			33,161		31,218		11%	10%
Total	$	3,259		$	106,807	$	103,548	100%	100%	$	(1,432	)	$	312,806	$	314,238	100%	100%

Net revenues for the three months ended September 27, 2014 were approximately $188.2 million, compared to approximately $181.3 million for the three months ended September 28, 2013. The net revenue increase year-over-year primarily reflects an approximate 21% increase in revenue in the commercial aerospace end-use markets that was partially offset by an approximate 3% decrease in revenue in the military and space end-use markets.

Net revenues for the nine months ended September 27, 2014 were approximately $554.4 million, compared to approximately $548.7 million for the nine months ended September 28, 2013. The net revenue increase year-over-year primarily reflects an approximate 10% increase in revenue in the commercial aerospace end-use markets and an approximate 4% increase in revenue in the non-aerospace and defense (“non-A&D”) end-use markets, partially offset by an approximate 5% decrease in revenue in the military and space end-use markets.

Net Revenues by Major Customers

A significant portion of our net revenues are to our top ten customers as follows:



	Three Months Ended				Nine Months Ended
	September 27, 2014		September 28, 2013		September 27, 2014		September 28, 2013
Boeing	21	%	19	%	20	%	18	%
Raytheon	9	%	10	%	9	%	10	%
Total top ten customers	61	%	60	%	59	%	57	%

Table of Contents

Boeing and Raytheon represented the following percentages of total accounts receivable:

The revenues and accounts receivable from Boeing and Raytheon are diversified over a number of commercial, military and space programs and were made by both operating segments.

Gross Profit

Gross profit margin was essentially flat but gross profit dollars increased year-over-year in the three months ended September 27, 2014 compared to the three months ended September 28, 2013 primarily due higher net revenue that was partially offset by higher accrued compensation and benefit costs and additional costs incurred as a result of a major outside supplier’s delay in deliveries.

Gross profit margins and dollars increased year-over-year in the nine months ended September 27, 2014 compared to the nine months ended September 28, 2013 primarily due to a favorable product mix, higher gross profit, and an approximately $0.8 million workers’ compensation audit refund related to prior years, partially offset by an increase in accrued compensation and benefit costs.

Selling, General and Administrative Expenses (“SG&A”)

SG&A expenses increased year-over-year in the three months ended September 27, 2014 compared to the three months ended September 28, 2013 primarily due to higher accrued compensation and benefit costs.

SG&A expenses decreased year over year in the nine months ended September 27, 2014 compared to the nine months ended September 28, 2013 primarily due to lower non-recurring professional fees combined with the prior year included an approximate $0.5 million charge related to the Company’s debt repricing transaction, partially offset by higher accrued compensation and benefit costs.

Interest Expense

Interest expense decreased year over year in the three months ended September 27, 2014 compared to the three months ended September 28, 2013 primarily due to lower outstanding debt balances and interest rate reduction as a result of repricing our term loan towards the end of the first quarter of 2013.

Interest expense decreased year over year in the nine months ended September 27, 2014 compared to the nine months ended September 28, 2013 primarily due to lower outstanding debt balances and interest rate reduction as a result of repricing our term loan towards the end of the first quarter of 2013.

Other Income

Other income for both the three months and nine months ended September 27, 2014 was made up of $1.6 million of insurance recoveries related to property and equipment.

Income Tax Expense

We recorded income tax expense of approximately $2.3 million (effective tax rate of 47.2%) for the three months ended September 27, 2014 compared to an income tax benefit of approximately $0.1 million (effective tax benefit rate of 1.9%) for the three months ended September 28, 2013. The effective tax rate for the three months ended September 27, 2014 did not include a benefit from the federal research and development (“R&D”) tax credit as it expired on December 31, 2013. The three months ended September 28, 2013 included a federal R&D tax credit benefit of approximately $0.7 million. The federal R&D tax credit has not yet been extended for 2014, therefore, there was no federal R&D tax credit benefit recognized in the three months ended September 27, 2014. In addition, the effective tax rate for the three months ended September 27, 2014 included a total of approximately $0.9 million additional tax expense as a result of lowering our Qualified Domestic Production Activities Deduction due to lower taxable income resulting from tax returns filed or to be filed.

We recorded income tax expense of approximately $7.7 million (effective tax rate of 35.9%) for the nine months ended September 27, 2014 compared to approximately $0.8 million (effective tax rate of 5.4%) for the nine months ended September 28, 2013. The effective tax rate for for the nine months ended September 27, 2014 did not include a benefit from the federal R&D tax credit as it expired on December 31, 2013. The nine months ended September 28, 2013 included a federal R&D tax credit benefit of approximately $3.7 million. This amount included approximately $2.0 million of 2012 federal research and development tax credit benefit recognized in the nine months ended September 28, 2013 as a result of the American Taxpayer Relief Act of 2012 (the “Act”) passed in January 2013. The Act included an extension of the federal research and development tax credit for amounts paid or incurred during 2012 and 2013. The

Table of Contents

federal R&D tax credit has not yet been extended for 2014, therefore, there was no federal R&D tax credit benefit recognized in the nine months ended September 27, 2014.

Net Income and Earnings per Diluted Share

Net income and earnings per diluted share for the three months ended September 27, 2014 were approximately $2.6 million, or $0.24 per diluted share, compared to approximately $4.6 million, or $0.42 per diluted share, for the three months ended September 28, 2013. Net income for the three months ended September 27, 2014 decreased primarily due to higher income tax expense and higher accrued compensation and benefit costs, partially offset by insurance recoveries related to property and equipment and lower interest expense.

Net income and earnings per diluted share for the nine months ended September 27, 2014 were approximately $13.7 million, or $1.23 per diluted share, compared to approximately $13.8 million, or $1.28 per diluted share, for the nine months ended September 28, 2013. Net income for the first nine months of fiscal 2014 compared to the comparable period of fiscal 2013 included higher income tax expense, partially offset by insurance recoveries related to property and equipment, higher revenue, higher gross profit, and lower interest expense.

Table of Contents

Business Segment Performance

We report our financial performance based upon the two reportable operating segments: DAS and DLT. The results of operations differ between our reportable operating segments due to differences in competitors, customers, extent of proprietary deliverables and performance. The following table summarizes our business segment performance for the three and nine months ended September 27, 2014 and September 28, 2013:



	Three Months Ended												Nine Months Ended
	%		(In thousands)						% of Net Revenues				%		(In thousands)						% of Net Revenues
	Change		September 27, 2014			September 28, 2013			September 27, 2014		September 28, 2013		Change		September 27, 2014			September 28, 2013			September 27, 2014		September 28, 2013
Net Revenues
DAS	4.7	%	$	81,357		$	77,740		43.2	%	42.9	%	3.1	%	$	241,627		$	234,437		43.6	%	42.7	%
DLT	3.1	%	106,807			103,548			56.8	%	57.1	%	(0.5	)%	312,806			314,238			56.4	%	57.3	%
Total Net Revenues	3.8	%	$	188,164		$	181,288		100.0	%	100.0	%	1.0	%	$	554,433		$	548,675		100.0	%	100.0	%
Segment Operating Income
DAS			$	7,190		$	7,633		8.8	%	9.8	%			$	27,269		$	23,766		11.3	%	10.1	%
DLT			8,288			7,596			7.8	%	7.3	%			26,089			26,772			8.3	%	8.5	%
			15,478			15,229									53,358			50,538
Corporate General and Administrative Expenses ⁽¹⁾			(5,134		)	(3,276		)	(2.7	)%	(1.8	)%			(12,456		)	(13,240		)	(2.2	)%	(2.4	)%
Total Operating Income			$	10,344		$	11,953		5.5	%	6.6	%			$	40,902		$	37,298		7.4	%	6.8	%
EBITDA
DAS
Operating Income			$	7,190		$	7,633								$	27,269		$	23,766
Other Income ⁽²⁾			1,600			—									1,600			—
Depreciation and Amortization			2,272			2,621									8,242			7,386
			11,062			10,254			13.6	%	13.2	%			37,111			31,152			15.4	%	13.3	%
DLT
Operating Income			8,288			7,596									26,089			26,772
Depreciation and Amortization			4,391			4,540									13,442			13,863
			12,679			12,136			11.9	%	11.7	%			39,531			40,635			12.6	%	12.9	%
Corporate General and Administrative Expenses ⁽¹⁾
Operating Loss			(5,134		)	(3,276		)							(12,456		)	(13,240		)
Depreciation and Amortization			41			41									145			126
			(5,093		)	(3,235		)							(12,311		)	(13,114		)
EBITDA			$	18,648		$	19,155		9.9	%	10.6	%			$	64,331		$	58,673		11.6	%	10.7	%


(1)	Includes costs not allocated to either the DLT or DAS operating segments.


(2)	Insurance recoveries related to property and equipment included as other income.

Ducommun AeroStructures

DAS’s net revenues in the three months ended September 27, 2014 compared to the three months ended September 28, 2013 increased approximately 5% primarily due to an approximate 15% increase in commercial aerospace revenue that was partially offset by an approximate 8% decrease in military and space revenue. DAS’s net revenues for the nine months ended September 27, 2014 compared to the nine months ended September 28, 2013 increased approximately 3% primarily due to an approximate 7% increase in commercial aerospace revenue that was partially offset by an approximate 3% decrease in military and space revenue.

The DAS segment operating income decreased in the three month period ending September 27, 2014 as a result of additional costs

Table of Contents

incurred as a result of a major outside supplier’s delay in deliveries that was partially offset by higher revenue. The DAS EBITDA increased during the three month period ended September 27, 2014 primarily due to $1.6 million of insurance recoveries related to property and equipment that was recorded as other income and none in the comparable period in 2013.

The DAS segment operating income and EBITDA increased in the nine month period ending September 27, 2014, as a result of a favorable product mix and a $0.8 million workers’ compensation audit refund related to prior years. The DAS EBITDA included $1.6 million of insurance recoveries related to property and equipment that was recorded as other income and none in the comparable period in 2013.

Ducommun LaBarge Technologies

DLT’s net revenues in the three months ended September 27, 2014 compared to the three months ended September 28, 2013 increased approximately 3% primarily due to an approximate 44% increase in commercial aerospace revenue. DLT's net revenues in the nine months ended September 27, 2014 compared to the nine months ended September 28, 2013 was essentially flat primarily due to an approximate 6% decrease in defense technologies revenue, partially offset by an an approximate 23% increase in commercial aerospace revenue and an approximate 4% increase in non-A&D revenue.

DLT’s segment operating income and EBITDA increased in the three month period ending September 27, 2014 compared to the three months ended September 28, 2013 as a result of an increase in revenue, favorable product mix, and improved operations, partially offset by higher accrued compensation and benefit costs. DLT’s segment operating income and EBITDA decreased in the nine month period ending September 27, 2014 compared to the nine months ended September 28, 2013 as result of higher accrued compensation and benefit costs and lower revenue, partially offset by favorable product mix.

Corporate General and Administrative (“CG&A”)

CG&A expenses increased approximately $1.9 million in the three months ending September 27, 2014 compared to the three months ended September 28, 2013 primarily due to higher accrued compensation and benefit costs. CG&A expenses decreased approximately $0.8 million in the nine months ending September 27, 2014 compared to the nine months ended September 28, 2013 primarily due to the the first quarter of 2013 that included an approximate $0.5 million charge related to our debt repricing transaction.

Backlog

Backlog is subject to delivery delays or program cancellations, which are beyond our control. Backlog is affected by timing differences in the placement of customer orders and tends to be concentrated in several programs to a greater extent than our net revenues. Backlog in non-aerospace and defense markets tends to be of a shorter duration and is generally fulfilled within a 3-month period. As a result of these factors, trends in our overall level of backlog may not be indicative of trends in our future net revenues. Approximately $455 million of total backlog is expected to be delivered over the next 12 months. The following table summarizes our backlog as of September 27, 2014 and December 31, 2013:

Table of Contents



	(In thousands)
	Change			September 27, 2014		December 31, 2013
Consolidated Ducommun
Military and space
Defense technologies	$	(38,448	)	$	179,005	$	217,453
Defense structures	(24,422		)	93,311		117,733
Commercial aerospace	(5,648		)	225,555		231,203
Natural resources	1,371			24,176		22,805
Industrial	10,094			23,710		13,616
Medical and other	5,737			22,920		17,183
Total	$	(51,316	)	$	568,677	$	619,993
DAS
Military and space (defense structures)	$	(24,422	)	$	93,311	$	117,733
Commercial aerospace	(17,669		)	187,861		205,530
Total	$	(42,091	)	$	281,172	$	323,263
DLT
Military and space (defense technologies)	$	(38,448	)	$	179,005	$	217,453
Commercial aerospace	12,021			37,694		25,673
Natural resources	1,371			24,176		22,805
Industrial	10,094			23,710		13,616
Medical and other	5,737			22,920		17,183
Total	$	(9,225	)	$	287,505	$	296,730

Liquidity and Capital Resources

Available Liquidity

Total debt, the weighted-average interest rate, cash and cash equivalents and available credit facilities were as follows:



	(In millions)
	September 27,			December 31,
	2014			2013
Total debt, including long-term portion	$	310.2		$	332.7
Weighted-average interest rate on debt	7.97		%	7.76		%
Term Loan interest rate	4.75		%	4.75		%
Cash and cash equivalents	$	40.9		$	48.8
Unused Revolving Credit Facility	$	58.5		$	58.4

We made a voluntary principal prepayment of approximately $7.5 million in each of the first three quarters of 2014 for a total aggregate voluntary principal prepayment of approximately $22.5 million on our term loan. We expect to pay down a total of $30.0 million to $40.0 million on the term loan in 2014.

The Revolving Credit Facility and Term Loan covenants require EBITDA of more than $50.0 million and a maximum leverage ratio under certain circumstances, as well as annual limitations on capital expenditures and limitations on future disposition of property, investments, acquisitions, repurchase of stock, dividends, and outside indebtedness. At September 27, 2014, we were in compliance with all covenants. At September 27, 2014, there were no amounts outstanding that would have triggered the leverage ratio covenant. However, we would have been in compliance with such coverage ratio.

We expect to spend a total of approximately $16.0 million for capital expenditures in 2014 financed by cash generated from operations, which would be higher than 2013, principally to support new contract awards at DAS and DLT. As part of our strategic plan to become a Tier 2 supplier, additional up-front investment in tooling will be required for newer programs which have higher engineering content and higher levels of complexity in assemblies.

Table of Contents

We continue to depend on operating cash flow and the availability of our Revolving Credit Facility to provide short-term liquidity. Cash generated from operations and bank borrowing capacity is expected to provide sufficient liquidity to meet our obligations during the next twelve months.

Cash Flow Summary

Net cash generated from operating activities for the nine months ended September 27, 2014 increased to approximately $20.9 million, compared to net cash generated of approximately $14.7 million in the nine months ended September 28, 2013. The higher cash generated during the first nine months of 2014 related primarily to improved working capital management.

Net cash used in investing activities of approximately $7.6 million for the nine months ended September 27, 2014 were primarily due to capital expenditures, principally to support new contract awards at DAS and DLT, partially offset by insurance recoveries related to property and equipment. The increase in net cash used compared to the prior year was primarily due to timing of capital expenditures.

Net cash used in financing activities for the nine months ended September 27, 2014 of approximately $21.2 million were primarily due to voluntary principal prepayments on our term loan.

Off-Balance Sheet Arrangements

Our off-balance sheet arrangements consist of operating leases and indemnities.

Critical Accounting Policies

The preparation of our condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States requires estimation and judgment that affect the reported amounts of net revenues, expenses, assets and liabilities. For a description of our critical accounting policies, please refer to “Critical Accounting Policies” in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our 2013 Annual Report on Form 10-K. There have been no material changes in any of our critical accounting policies during the three and nine months ended September 27, 2014.

Recent Accounting Pronouncements

See “Part I, Item 1. Ducommun Incorporated and Subsidiaries—Notes to Condensed Consolidated Financial Statements—Note 1. Summary of Significant Accounting Policies—Recent Accounting Pronouncements” for further information.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Our main market risk exposure relates to changes in U.S. interest rates on our outstanding long-term debt. At September 27, 2014, we had borrowings of approximately $110.1 million under our Term Loan which bears interest, at our option, at a rate equal to either an alternate base rate or an adjusted LIBOR rate for a one-, two-, three-, or six-month interest period chosen by us, plus an applicable margin percentage. This LIBOR rate has a floor of 1.00%, and a margin of 3.75%. A hypothetical 10% increase or decrease in the interest rate would have an immaterial impact on our financial condition and results of operations.

Item 4. Controls and Procedures

Disclosure Controls and Procedures

The Company’s chief executive officer and chief financial officer have concluded, based on an evaluation of the Company’s disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rules 13a-15(e) and 15d-15(e)), that such disclosure controls and procedures were effective as of the end of the period covered by this report.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the three months ended September 27, 2014 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

Subsequent to our quarter ended September 27, 2014, on October 8, 2014, the United States District Court for the District of Kansas (the “District Court”) granted summary judgment in favor of Boeing and Ducommun Incorporated and dismissed the

Table of Contents

lawsuit entitled United States of America ex rel Taylor Smith, Jeannine Prewitt and James Ailes v. The Boeing Company and Ducommun Inc. For a description of the lawsuit, see Note 10, “Contingencies,” in the accompanying notes to condensed consolidated financial statements included in Part I, Item 1 of this Form 10-Q for a description of our legal proceedings.

Item 1A. Risk Factors

See Part I, Item 1A, “Risk Factors,” of our Annual Report on Form 10-K for the year ended December 31, 2013 for discussion of risk factors. There have been no material changes in the nine months ended September 27, 2014 to the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2013.

Item 4. Mine Safety Disclosures

Not applicable.

Table of Contents

Item 6. Exhibits


2.1	Agreement and Plan of Merger, dated as of April 3, 2011, among Ducommun Incorporated, DLBMS, Inc. and LaBarge, Inc. Incorporated by reference to Exhibit 2.1 to Form 8-K filed on April 5, 2011.


3.1	Restated Certificate of Incorporation filed with the Delaware Secretary of State on May 29, 1990. Incorporated by reference to Exhibit 3.1 to Form 10-K for the year ended December 31, 1990.


3.2	Certificate of Amendment of Certificate of Incorporation filed with the Delaware Secretary of State on May 27, 1998. Incorporated by reference to Exhibit 3.2 to Form 10-K for the year ended December 31, 1998.


3.3	Bylaws as amended and restated on March 19, 2013. Incorporated by reference to Exhibit 99.1 to Form 8-K dated March 22, 2013.


3.4	Amendment No. 2 to Bylaws dated August 1, 2013. Incorporated by reference to Exhibit 99.2 to Form 8-K dated August 5, 2013.


4.1	Indenture, dated June 28, 2011, between Ducommun Incorporated, certain of its subsidiaries and Wilmington Trust FSB, as trustee. Incorporated by reference to Exhibit 4.1 to Form 8-K filed on July 1, 2011.


4.2	Registration Rights Agreement, dated June 28, 2011, between Ducommun Incorporated, certain of its subsidiaries, UBS Securities LLC and Credit Suisse Securities (USA) LLC. Incorporated by reference to Exhibit 4.2 to Form 8-K filed on July 1, 2011.


10.1	Commitment Letter to Ducommun Incorporated, dated April 3, 2011 from UBS Loan Finance LLC and UBS Securities LLC, Credit Suisse Securities (USA) LLC and Credit Suisse AG. Incorporated by reference to Exhibit 10.1 to Form 8-K filed on April 5, 2011.


10.2	Credit Agreement, dated as of June 28, 2011, among Ducommun Incorporated, certain of its subsidiaries, UBS Securities LLC and Credit Suisse Securities (USA) LLC as joint lead arrangers, UBS AG, Stamford Branch as issuing bank, administrative agent and collateral agent, and other lenders party thereto. Incorporated by reference to Exhibit 10.1 to Form 8-K filed on July 1, 2011.


10.3	Amendment No. 1 to Credit Agreement, dated as of March 28, 2013, by and among Ducommun Incorporated, certain of its subsidiaries, UBS AG, Stamford Branch as administrative agent, collateral agent, swingline bank and issuing bank and other lenders party thereto. Incorporated by reference to Exhibit 10.1 to Form 8-K dated March 28, 2013.


10.4	Amendment No. 2 to Credit Agreement, dated as of October 18, 2013 by and among Ducommun Incorporated, certain of its subsidiaries, and UBS AG, Stamford Branch, as administrative agent, collateral agent, swingline bank and issuing bank, and other lenders party thereto. Incorporated by reference to Exhibit 10.1 to Form 8-K dated October 23, 2013.

*10.13

Form of Key Executive Severance Agreement entered with seven current executive officers of Ducommun. Incorporated by reference to Exhibit 99.1 to Form 8-K dated January 9, 2008. Incorporated by reference to Exhibit 99.1 to Form 8-K dated January 9, 2008. All of the Key Executive Severance Agreements are identical except for the name of the executive officer, the address for notice, and the date of the Agreement:



	Executive Officer		Date of Agreement
	Kathryn M. Andrus		February 18, 2014
	Joseph P. Bellino		November 5, 2009
	Joel H. Benkie		December 13, 2013
	Douglas L. Groves		February 18, 2014
	James S. Heiser		December 31, 2007
	Anthony J. Reardon		December 31, 2007
	Rose F. Rogers		November 5, 2009

Table of Contents


*10.14	Form of Indemnity Agreement entered with all directors and officers of Ducommun. Incorporated by reference to Exhibit 10.8 to Form 10-K for the year ended December 31, 1990. All of the Indemnity Agreements are identical except for the name of the director or officer and the date of the Agreement:



	Director/Officer		Date of Agreement
	Kathryn M. Andrus		January 30, 2008
	Richard A. Baldridge		March 19, 2013
	Joseph C. Berenato		November 4, 1991
	Joseph P. Bellino		September 15, 2008
	Joel H. Benkie		February 12, 2013
	Gregory S. Churchill		March 19, 2013
	Robert C. Ducommun		December 31, 1985
	Dean W. Flatt		November 5, 2009
	Douglas L. Groves		February 12, 2013
	Jay L. Haberland		February 2, 2009
	James S. Heiser		May 6, 1987
	Robert D. Paulson		March 25, 2003
	Anthony J. Reardon		January 8, 2008
	Rosalie F. Rogers		July 24, 2008


*10.17	Employment Letter Agreement dated September 5, 2008 between Ducommun Incorporated and Joseph P. Bellino. Incorporated by reference to Exhibit 99.1 to Form 8-K dated September 18, 2008.


*10.18	Employment Letter Agreement dated May 3, 2012 between Ducommun Incorporated and Joel H. Benkie. Incorporated by reference to Exhibit 99.1 to Form 8-K dated June 4, 2012.


*10.19	Form of Performance Stock Unit Agreement for 2014 and after.


31.1	Certification of Principal Executive Officer.


31.2	Certification of Principal Financial Officer.


32	Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.


101.INS	XBRL Instance Document

101.SCH XBRL Taxonomy Extension Schema

101.CAL XBRL Taxonomy Extension Calculation Linkbase

101.DEF XBRL Taxonomy Extension Definition Linkbase

101.LAB XBRL Taxonomy Extension Label Linkbase

101.PRE XBRL Taxonomy Extension Presentation Linkbase

___________________

* Indicates an executive compensation plan or arrangement.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



Date: October 27, 2014	By:	/s/ Anthony J. Reardon
		Anthony J. Reardon
		Chairman and Chief Executive Officer
		(Principal Executive Officer)

Date: October 27, 2014	By:	/s/ Joseph P. Bellino
		Joseph P. Bellino
		Vice President, Treasurer and Chief Financial Officer
		(Principal Financial Officer)

Date: October 27, 2014	By:	/s/ Douglas L. Groves
		Douglas L. Groves
		Vice President, Controller and Chief Accounting Officer
		(Principal Accounting Officer)

September 27, 2014

December 31, 2013